Products & Services · Revenue

Contract manufacturing & human health — Revenue

Zoetis Contract manufacturing & human health — Revenue decreased by 23.3% to $23.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 20.7%, from $29.00M to $23.00M. Over 4 years (FY 2021 to FY 2025), Contract manufacturing & human health — Revenue shows an upward trend with a 9.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026
Rolls up toTotal Revenue

How to read this metric

An increase suggests successful monetization of manufacturing assets or growth in the human diagnostics market, while a decrease may indicate reduced external demand or a strategic shift toward core animal health focus.

Detailed definition

This metric represents the total revenue generated from contract manufacturing services provided to third parties and th...

Peer comparison

Peers in the life sciences or pharmaceutical sector often report similar 'other revenue' or 'contract services' segments, which are typically evaluated based on their contribution margin relative to core business lines.

Metric ID: zts_segment_contract_manufacturing_human_health_revenue

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$20.50M$20.50M$20.50M$21.50M$21.50M$21.50M$21.50M$19.50M$19.50M$19.50M$19.50M$20.00M$18.00M$21.00M$21.00M$29.00M$34.00M$23.00M$30.00M$23.00M
QoQ Change+0.0%+0.0%+4.9%+0.0%+0.0%+0.0%-9.3%+0.0%+0.0%+0.0%+2.6%-10.0%+16.7%+0.0%+38.1%+17.2%-32.4%+30.4%-23.3%
YoY Change+4.9%+4.9%+4.9%-9.3%-9.3%-9.3%-9.3%+2.6%-7.7%+7.7%+7.7%+45.0%+88.9%+9.5%+42.9%-20.7%
Range$18.00M$34.00M
CAGR+2.5%
Avg YoY Growth+9.6%
Median YoY Growth+4.9%

Frequently Asked Questions

What is Zoetis's contract manufacturing & human health — revenue?
Zoetis (ZTS) reported contract manufacturing & human health — revenue of $23.00M in Q1 2026.
How has Zoetis's contract manufacturing & human health — revenue changed year-over-year?
Zoetis's contract manufacturing & human health — revenue decreased by 20.7% year-over-year, from $29.00M to $23.00M.
What is the long-term trend for Zoetis's contract manufacturing & human health — revenue?
Over 4 years (2021 to 2025), Zoetis's contract manufacturing & human health — revenue has grown at a 9.1% compound annual growth rate (CAGR), from $82.00M to $116.00M.
What does contract manufacturing & human health — revenue mean?
Revenue earned from manufacturing products for other companies and selling human health diagnostic tools.